Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28407 | 15167162 | Eur J Gastroenterol Hepatol | Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. | 2004 | Details |
| A28408 | 15166226 | J Biol Chem | Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | 2004 | Details |
| A28409 | 15151626 | J Gastroenterol Hepatol | Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. | 2004 | Details |
| A28410 | 15144045 | Rev Invest Clin | [An update on non-alcoholic fatty liver disease]. | 2004 | Details |
| A28412 | 15119115 | Orv Hetil | [Role of lipid peroxidation in non-alcoholic steatohepatitis]. | 2004 | Details |
| A28413 | 15115972 | Ann Hepatol | Development of a liver unit in Latin America. | 2004 | Details |
| A28414 | 15115959 | Ann Hepatol | Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report. | 2004 | Details |
| A28415 | 15114294 | Ann Hepatol | Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. | 2004 | Details |
| A28416 | 15114291 | Ann Hepatol | Treatment of nonalcoholic fatty liver disease. | 2004 | Details |
| A28417 | 15104027 | J Insur Med | Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. | 2004 | Details |
| A28418 | 15088419 | Pol Arch Med Wewn | [The assessment of nonalcoholic fatty liver disease detected by computed tomography in cases with obesity and overweight]. | 2004 | Details |
| A28419 | 15085490 | Semin Liver Dis | The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. | 2004 | Details |
| A28420 | 15085483 | Semin Liver Dis | Nonalcoholic steatohepatitis. | 2004 | Details |
| A28421 | 15084161 | Am J Transplant | Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. | 2004 | Details |
| A28422 | 15082596 | Gut | Long term prognosis of fatty liver: risk of chronic liver disease and death. | 2004 | Details |
| A28423 | 15057893 | Hepatology | Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. | 2004 | Details |
| A28424 | 15053039 | Korean J Intern Med | Factors associated or related to with pathological severity of nonalcoholic fatty liver disease. | 2004 | Details |
| A28425 | 15048596 | Turk J Gastroenterol | The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis. | 2003 | Details |
| A28426 | 15046183 | Dig Liver Dis | Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? | 2004 | Details |
| A28428 | 15017657 | Clin Gastroenterol Hepatol | Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity. | 2003 | Details |
| A28429 | 15017611 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2004 | Details |
| A28430 | 15013444 | Biochem Biophys Res Commun | Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. | 2004 | Details |
| A28431 | 15012772 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? | 2004 | Details |
| A28432 | 14991537 | Hum Pathol | Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. | 2004 | Details |
| A28434 | 14975757 | Biochem Biophys Res Commun | Acarbose attenuates experimental non-alcoholic steatohepatitis. | 2004 | Details |
| A28435 | 14969505 | Obes Rev | Hepatic steatosis in obese patients: clinical aspects and prognostic significance. | 2004 | Details |
| A28436 | 14960526 | Gut | Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. | 2004 | Details |
| A28437 | 14762843 | Liver Transpl | Obesity and diabetes as a risk factor for hepatocellular carcinoma. | 2004 | Details |
| A28438 | 14762795 | Gastroenterology | Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. | 2004 | Details |
| A28439 | 14752836 | Hepatology | Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. | 2004 | Details |
| A28440 | 14739055 | Diabetes Res Clin Pract | Non-alcoholic steatohepatitis in patients cared in metabolic units. | 2004 | Details |
| A28441 | 14734144 | Hepatol Res | CYP2E1: from ASH to NASH. | 2004 | Details |
| A28442 | 14720121 | Clin Sci (Lond) | Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. | 2004 | Details |
| A28443 | 14708419 | J Int Med Res | A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). | 2004 | Details |
| A28444 | 14705824 | Dig Dis Sci | Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. | 2003 | Details |
| A28445 | 14696473 | Hepatogastroenterology | Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. | 2004 | Details |
| A28446 | 14685853 | Virchows Arch | Non-alcoholic fatty liver disease: an emerging pathological spectrum. | 2003 | Details |
| A28447 | 14678277 | Clin Exp Immunol | 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? | 2004 | Details |
| A28448 | 14672613 | J Hepatol | The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. | 2004 | Details |
| A28449 | 14671152 | J Clin Endocrinol Metab | Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. | 2003 | Details |
| A28450 | 14642613 | J Hepatol | Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. | 2003 | Details |
| A28451 | 14631324 | Diabetes Metab | Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. | 2003 | Details |
| A28452 | 14620622 | Dig Liver Dis | Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance. | 2003 | Details |
| A28453 | 14613504 | Nutr J | Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. | 2003 | Details |
| A28454 | 14610526 | Int J Obes Relat Metab Disord | Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. | 2004 | Details |
| A28455 | 14609346 | Drugs | Advances in the understanding and treatment of nonalcoholic fatty liver disease. | 2003 | Details |
| A28456 | 14604432 | Clin Sci (Lond) | Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? | 2004 | Details |
| A28457 | 14599934 | Hepatobiliary Pancreat Dis Int | Non-alcoholic fatty liver disease: the problems we are facing. | 2003 | Details |
| A28458 | 14598660 | Ryumachi | [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report]. | 2003 | Details |
| A28459 | 14585234 | Curr Treat Options Gastroenterol | Treatment of Nonalcoholic Fatty Liver Disease. | 2003 | Details |
| A28460 | 14582465 | Acta Med Croatica | [Non-alcoholic steatohepatitis]. | 2003 | Details |
| A28461 | 14571229 | J Pediatr | Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. | 2003 | Details |
| A28462 | 14564188 | J Clin Gastroenterol | Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? | 2004 | Details |
| A28463 | 14561231 | BMC Gastroenterol | Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. | 2003 | Details |
| A28464 | 14556645 | Clin Sci (Lond) | Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. | 2004 | Details |
| A28465 | 14535984 | J Gastroenterol Hepatol | Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. | 2003 | Details |
| A28466 | 14525603 | Am J Transplant | De novo non-alcoholic fatty liver disease following orthotopic liver transplantation. | 2003 | Details |
| A28467 | 14499789 | Am J Gastroenterol | Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. | 2003 | Details |
| A28469 | 13679007 | Med Hypotheses | Low birth weight: a possible risk factor also for liver diseases in adult life? | 2003 | Details |
| A28470 | 12971963 | J Hepatol | Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. | 2003 | Details |
| A28471 | 12923365 | Eur J Gastroenterol Hepatol | Serum hyaluronate correlates with histological progression in alcoholic liver disease. | 2003 | Details |
| A28472 | 12908728 | Eur Rev Med Pharmacol Sci | Experimental observations and clinical implications of fasting and diet supplementation in fatty livers. | 2003 | Details |
| A28473 | 12883726 | Oncol Rep | Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate. | 2004 | Details |
| A28474 | 12879992 | Clin Liver Dis | Hepatotoxicity of hypolipidemic drugs. | 2003 | Details |
| A28475 | 12799409 | JAMA | Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. | 2003 | Details |
| A28476 | 12774006 | Hepatology | Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. | 2003 | Details |
| A28477 | 12768215 | Rev Gastroenterol Peru | [Non-alcoholic fatty liver]. | 2003 | Details |
| A28478 | 12749246 | Hepatogastroenterology | Insulin resistance in patients with steatohepatitis. | 2003 | Details |
| A28479 | 12739988 | Expert Opin Pharmacother | Current best treatment for non-alcoholic fatty liver disease. | 2003 | Details |
| A28480 | 12734049 | Curr Gastroenterol Rep | Nonalcoholic steatohepatitis in children. | 2003 | Details |
| A28481 | 12730884 | Gastroenterology | Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. | 2003 | Details |
| A28483 | 12702913 | Eur J Gastroenterol Hepatol | Diagnosis of fatty liver disease: is biopsy necessary? | 2003 | Details |
| A28484 | 12694079 | Aliment Pharmacol Ther | Review article: Non-alcoholic fatty liver disease. | 2003 | Details |
| A28485 | 12677986 | Ugeskr Laeger | [Nonalcoholic steatohepatitis. Three case reports]. | 2003 | Details |
| A28486 | 12677985 | Ugeskr Laeger | [Nonalcoholic steatohepatitis--a "new" hepatic disease]. | 2003 | Details |
| A28487 | 12668987 | Hepatology | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. | 2003 | Details |
| A28488 | 12663231 | J Hepatol | Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study. | 2003 | Details |
| A28489 | 12643175 | Curr Diab Rep | Hepatic steatosis and type 2 diabetes mellitus. | 2002 | Details |
| A28492 | 12560853 | Can J Gastroenterol | Nonalcoholic fatty liver disease in patients investigated for elevated liver enzymes. | 2003 | Details |
| A28493 | 12542595 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? | 2003 | Details |
| A28494 | 12540784 | Hepatology | Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. | 2003 | Details |
| A28495 | 12538076 | Prostaglandins Leukot Essent Fatty Acids | Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms. | 2003 | Details |
| A28496 | 12530944 | Curr Gastroenterol Rep | Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. | 2003 | Details |
| A28497 | 12516196 | Clin Liver Dis | The liver in obesity and type 2 diabetes mellitus. | 2002 | Details |
| A28498 | 12508671 | Praxis (Bern 1994) | [Rare, but important chronic liver diseases]. | 2002 | Details |
| A28499 | 12506331 | Swiss Med Wkly | Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations. | 2002 | Details |
| A28500 | 12499997 | J Pediatr Gastroenterol Nutr | The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. | 2003 | Details |
| A28502 | 12468416 | Best Pract Res Clin Endocrinol Metab | Obesity and liver disease. | 2002 | Details |
| A28503 | 12453271 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: an overview. | 2002 | Details |
| A28504 | 12447858 | Hepatology | NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. | 2002 | Details |
| A28505 | 12420035 | Can J Gastroenterol | Motion - all patients with NASH need to have a liver biopsy: arguments against the motion. | 2002 | Details |
| A28506 | 12420034 | Can J Gastroenterol | Motion - all patients with NASH need to have a liver biopsy: arguments for the motion. | 2002 | Details |
| A28507 | 12406446 | Best Pract Res Clin Gastroenterol | Treatment of non-alcoholic steatohepatitis. | 2002 | Details |
| A28508 | 12406445 | Best Pract Res Clin Gastroenterol | Other disease associations with non-alcoholic fatty liver disease (NAFLD). | 2002 | Details |
| A28509 | 12406444 | Best Pract Res Clin Gastroenterol | Interaction of non-alcoholic fatty liver disease with other liver diseases. | 2002 | Details |
| A28510 | 12406443 | Best Pract Res Clin Gastroenterol | Steatohepatitis in children. | 2002 | Details |
| A28511 | 12406442 | Best Pract Res Clin Gastroenterol | Steatohepatitis in obese individuals. | 2002 | Details |
| A28512 | 12406441 | Best Pract Res Clin Gastroenterol | The metabolic abnormalities associated with non-alcoholic fatty liver disease. | 2002 | Details |
| A28513 | 12406440 | Best Pract Res Clin Gastroenterol | Pathology of steatohepatitis. | 2002 | Details |
| A28514 | 12406439 | Best Pract Res Clin Gastroenterol | Animal models of steatohepatitis. | 2002 | Details |